Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by BearDownAZon Sep 26, 2019 10:01pm
211 Views
Post# 30168931

RE:RE:RE:should we hit 30% RRR or anything above 25% is good ?

RE:RE:RE:should we hit 30% RRR or anything above 25% is good ?Barsax,

You're welcome. But I am just one contributor. As I wrote on the other board earlier:

"It has been quite the journey and I am grateful for all of the dialogue on this forum and others surrounding Resverlogix, epigenetics, BET inhibitors, cardiovascular/renal/cognitive/diabetes. I must extend a thank you to those who have asked the hard questions and challenged me to investigate and learn. My posts and ideas are a product of the stimulating and productive conversations on this and other forums. I have learned so much from everyone. So I appreciate the compliments, but this is no one man show. I'm strong in the science and critical thinking, but I am naive in most things business and investing. So thank you to all who fill in those gaps. What started off for me as a side interest in a novel apo-AI/HDL drug has turned out to be a stepping stone to a goldmine of information and experience that I hope to apply to future endeavors. And a big shout out should go to JDStox, whose Resverlogix blog and posts on Stockhouse I found long ago that started my obsession with posting about Resverlogix on Stockhouse and then Agoracom. Thanks JD!
 
Good luck to all. In the next few days, we'll be drinking to celebrate or mourn. Hopefully the former!
 
BearDownAZ"
Bullboard Posts